Literature DB >> 3121673

Experimental chemotherapy-induced skin necrosis in swine. Mechanistic studies of anthracycline antibiotic toxicity and protection with a radical dimer compound.

S D Averbuch1, M Boldt, G Gaudiano, J B Stern, T H Koch, N R Bachur.   

Abstract

The reactivity of antitumor anthracycline and mitomycin C antibiotics with the oxomorpholinyl radical dimers, bi(3,5,5-trimethyl-2-oxomorpholin-3-yl) (TM3) and bi(3,5-dimethyl-5-hydroxymethyl-2-oxomorpholin-3-yl) (DHM3), was studied in vitro. The oxomorpholinyl radical reduced daunorubicin to a quinone methide intermediate that reacted with solvent to form 7-deoxydaunorubicinone. The solvolysis reaction followed first order kinetics, and the reactivity rate constants (k2) measured for seven anthracycline analogues ranged from 2 X 10(-2) s-1 to 8.0 X 10(-4) s-1. The chemical reactivity of each anthracycline quinone methide correlated with the total skin toxicity caused by the respective parent anthracycline following injection into swine skin. Microscopic examination of experimental lesions in swine skin resemble those observed in humans after inadvertant chemotherapy extravasation. Hydrocortisone sodium succinate was not effective for the treatment of doxorubicin-induced skin necrosis, whereas DHM3 was effective for the treatment of skin necrosis caused by all seven anthracyclines and by the quinone containing antibiotic, mitomycin C.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3121673      PMCID: PMC442485          DOI: 10.1172/JCI113285

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Nursing management of adriamycin extravasation.

Authors:  A L Barlock; D M Howser; S M Hubbard
Journal:  Am J Nurs       Date:  1979-01       Impact factor: 2.220

2.  Transplantation in miniature swine. I. Fixation of the major histocompatibility complex.

Authors:  D H Sachs; G Leight; J Cone; S Schwarz; L Stuart; S Rosenberg
Journal:  Transplantation       Date:  1976-12       Impact factor: 4.939

3.  Skin ulcers due to adriamycin.

Authors:  R Rudolph; R S Stein; R A Pattillo
Journal:  Cancer       Date:  1976-09       Impact factor: 6.860

4.  Bioactivation as a model for drug design bioreductive alkylation.

Authors:  H W Moore
Journal:  Science       Date:  1977-08-05       Impact factor: 47.728

5.  Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease.

Authors:  J J Wang; E Cortes; L F Sinks; J F Holland
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

6.  Characteristics and effect of antiinflammatory drugs on adriamycin-induced inflammation in the mouse paw.

Authors:  D M Siegel; S N Giri; R M Scheinholtz; L W Schwartz
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

7.  Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs.

Authors:  R J Ignoffo; M A Friedman
Journal:  Cancer Treat Rev       Date:  1980-03       Impact factor: 12.111

8.  Skin permeability in vivo: comparison in rat, rabbit, pig and man.

Authors:  M J Bartek; J A LaBudde; H I Maibach
Journal:  J Invest Dermatol       Date:  1972-03       Impact factor: 8.551

9.  The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse.

Authors:  R T Dorr; D S Alberts; H S Chen
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

10.  Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen.

Authors:  V Berlin; W A Haseltine
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

View more
  3 in total

Review 1.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

2.  Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function.

Authors:  P S Mushlin; B J Cusack; R J Boucek; T Andrejuk; X Li; R D Olson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

3.  Protective effect of doxorubicin in vitamin C or dimethyl sulfoxide against skin ulceration in the pig.

Authors:  H Hajarizadeh; L Lebredo; R Barrie; E A Woltering
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.